A rapid in vitro drug-sensitivity assay in acute nonlymphocytic leukemia
β Scribed by Michael E. Theodorakis; Jack Goldberg
- Book ID
- 102698030
- Publisher
- John Wiley and Sons
- Year
- 1983
- Tongue
- English
- Weight
- 607 KB
- Volume
- 15
- Category
- Article
- ISSN
- 0361-8609
No coin nor oath required. For personal study only.
β¦ Synopsis
Leukemic myeloid, myelomonocytic, and monocytic cells will incorporate radiolabeled sulfate into newly synthesized macromolecules. We developed a liquid culture technique to examine the in vitro effects of chemotherapeutic agents on the incorporation of radiolabeled sulfate into cells of patients with acute nonlymphocytic leukemia (ANLL). Cells recovered from bone marrow or peripheral blood of 25 patients with ANLL were incubated in vitro for one hour with saline (control) or a variety of chemotherapeutic agents. Cells were washed free of the drug and grown in liquid cultures containing nutrient medium and 35S04. The percent of 35S04 incorporated into the drug treated as compared with control cells was determined after one, three, and seven days of culture. Patients whose drugtreated cells incorporated less than 30% of '%04 when compared with the control after three or seven days of culture achieved a complete response to these agents in vivo (P < .05). Thus, the in vitro effects of various chemotherapeutic agents on the incorporation of 35S04 into cells obtained from patients with ANLL may help predict clinical response to these agents in vivo.
π SIMILAR VOLUMES
Mitoxantrone is a substituted anthraquinone with considerable activity against human acute leukemia. The authors' goal was to treat patients with continuous infusion mitoxantrone in order to maintain cytotoxic steady state levels with acceptable toxicity and to assess the results. Daily mitoxantrone